Advertisement
Screener

Penumbra, Inc (PEN) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

2.8 / 5 stars · 68/120 Roast Me

Penumbra, Inc Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

Penumbra, Inc (PEN) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $11.36 million as of 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-02-25

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $11.36M.
  • 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $9.45M.
  • 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $9.11M.
  • 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $12.48M.
Period endDeferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
2025-12-31$11.36M
10-K · filed 2026-02-25
2024-12-31$9.45M
10-K · filed 2026-02-25
2023-12-31$9.11M
10-K · filed 2025-02-18
2022-12-31$12.48M
10-K · filed 2024-02-22
2021-12-31$21.89M
10-K · filed 2023-02-23
2020-12-31$4.56M
10-K · filed 2022-02-22
2019-12-31$4.25M
10-K · filed 2021-02-23
2019-06-30$3.48M
10-K · filed 2020-02-26
2018-12-31$3.48M
10-K · filed 2019-02-26
2017-12-31$3.08M
10-K · filed 2019-02-26
2016-12-31$3.70M
10-K · filed 2018-02-27
2015-12-31$1.35M
10-K · filed 2017-02-28
2014-12-31$416.00K
10-K · filed 2016-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Solventum Corp (SOLV)United States$15.085B9.16
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B